Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults
Clinical trial NCT01195038 · COMPLETED
Trial details
- NCT number
- NCT01195038
- Sponsor
- UMN Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-01-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.